“Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients With Moderate-to-Severe Genital Psoriasis”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S8, https://doi.org/10.25251/skin.2.supp.8.